1987
DOI: 10.1097/00006254-198710000-00015
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Cyproterone-Containing Oral Contraceptive on Hormonal Levels in Polycystic Ovarian Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1988
1988
1989
1989

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Other investigators have successfully used an other antiandrogen, cyproterone acetate, as the pro gestational agent in an OCP for the treatment of hirsutism. 63 The cyclic administration of estrogens with regular monthly progestin withdrawals, as in menopausal hormone replacement, is moderately ef fective in the treatment of hirsutism. 64 Estrogen alone, however, produces significantly less inhibi tion of circulating levels of gonadotropins than do estrogen/progestin combinations 6 and may increase adrenal androgen secretions.…”
Section: Variations In Oral Contraceptive Preparation Therapymentioning
confidence: 99%
“…Other investigators have successfully used an other antiandrogen, cyproterone acetate, as the pro gestational agent in an OCP for the treatment of hirsutism. 63 The cyclic administration of estrogens with regular monthly progestin withdrawals, as in menopausal hormone replacement, is moderately ef fective in the treatment of hirsutism. 64 Estrogen alone, however, produces significantly less inhibi tion of circulating levels of gonadotropins than do estrogen/progestin combinations 6 and may increase adrenal androgen secretions.…”
Section: Variations In Oral Contraceptive Preparation Therapymentioning
confidence: 99%